StratifiCare™ Pte. Ltd.

StratifiCare™ Pte. Ltd. is dedicated to advancing personalized medicine through the development and manufacturing of innovative in-vitro diagnostic (IVD) assay solutions. With a wealth of experience in biomedical R&D and technology commercialization, StratifiCare™ is committed to empowering healthcare professionals with the tools they need for precise and effective patient care. The company operates in accordance with the ISO13485 international quality standard, ensuring the highest levels of product quality and reliability.

StratifiCare™ focuses on creating value by supporting physicians in making informed decisions that improve clinical and socioeconomic outcomes. Their Severe Dengue Prediction Solution exemplifies their commitment to providing cutting-edge diagnostic tools. Located at Blk 83, #08-02, 535 Clementi Rd, Singapore, Singapore 599489, SG, StratifiCare™ is strategically positioned to serve the global healthcare market with its advanced diagnostic solutions.

StratifiCare™ aims to revolutionize patient care by offering high-quality diagnostics that enable personalized treatment strategies. The company’s dedication to innovation and quality makes them a trusted partner for healthcare providers worldwide. StratifiCare™ is continuously expanding its portfolio of IVD solutions to meet the evolving needs of the medical community. We invite the management team at StratifiCare™ to create a customized and exclusive company showcase and product listing on our platform to further enhance their market presence.